Algert Global LLC Lantheus Holdings, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Algert Global LLC holds 49,714 shares of LNTH stock, worth $4.85 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

49,714

Previous 127,340 60.96%

Holding current value

$4.85 Million

Previous $10.2 Million 46.64%

% of portfolio

0.15%

Previous 0.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$77.7 - $123.62 $6.03 Million - $9.6 Million	-77,626 Reduced 60.96%	49,714 $5.46 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $1.54 Million - $2.18 Million	-26,207 Reduced 17.07%	127,340 $10.2 Million
Q1 2024 May 14, 2024	BUY	$51.07 - $68.26 $5.42 Million - $7.24 Million	106,033 Added 223.16%	153,547 $9.56 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $2.54 Million - $3.56 Million	-45,682 Reduced 49.02%	47,514 $2.95 Million
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $2.44 Million - $3.67 Million	40,480 Added 76.79%	93,196 $6.48 Million
Q2 2023 Aug 14, 2023	SELL	$82.41 - $99.65 $4.59 Million - $5.55 Million	-55,709 Reduced 51.38%	52,716 $4.42 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $593,131 - $1.03 Million	12,419 Added 12.94%	108,425 $8.95 Million
Q4 2022 Feb 13, 2023	BUY	$48.76 - $77.67 $886,993 - $1.41 Million	18,191 Added 23.38%	96,006 $4.89 Million
Q3 2022 Nov 15, 2022	BUY	$61.42 - $86.29 $1.72 Million - $2.42 Million	28,049 Added 56.36%	77,815 $5.47 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $2.16 Million - $2.83 Million	38,920 Added 358.84%	49,766 $3.29 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $263,340 - $614,317	10,846 New	10,846 $600,000

Others Institutions Holding LNTH

# of Institutions

538

Shares Held

68.4M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Lantheus Holdings, Inc. Transaction History